MedPath

Assessing antibiotic therapy in ICU patients with infections

Recruiting
Registration Number
CTRI/2023/08/056619
Lead Sponsor
Hari Naveen Ashok Kumar
Brief Summary

We seek to evaluate appropriateness of empirical antibiotic therapy for community acquired infections in critically ill patients and its effect on outcomes. We also seek to evaluate our concordance with current guidelines.

Primary outcomes measured are mortality at 28 days. Secondary outcomes are ventilator free days, vasopressor free days, renal replacement free days at 28 days and length of ICU stay and hospital stay. ICMR guidelines and ISCCM guidelines for tropical illness are used to compare concordance.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
96
Inclusion Criteria

1.All adults patients admitted into ICU from ER with suspicion of community acquired infection and started on empirical antibiotics 2.Antibiotics started within 48 hours of admission to ICU and continued for atleast 24 hours.

Exclusion Criteria

1.Patients with indwelling catheters (central venous catheters, haemodialysis catheters, urinary catheters, chemo port, peripherally inserted central catheter, etc) prior to admission 2.History of hospitalization for more than 2 days in the preceding 30 days 3.History of Antibiotic usage in the preceding 30 days.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Concordance with current guidelines28 days
2.Appropriateness of empirical antibiotic therapy & its effect on Mortality at 28 days28 days
Secondary Outcome Measures
NameTimeMethod
•Appropriateness of empirical antibiotic therapy & its effect on ventilator free days at 28-day, vasopressor free days at 28-day, renal replacement therapy free days at 28-day, length of ICU stay and length of hospital stay28 days

Trial Locations

Locations (1)

Apollo Hospital

🇮🇳

Chennai, TAMIL NADU, India

Apollo Hospital
🇮🇳Chennai, TAMIL NADU, India
Dr Hari Naveen Ashok Kumar
Principal investigator
9940537733
harinaveen19@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.